Department of Epidemiology, University of Iowa College of Public Health, Iowa City.
Carver College of Medicine, Department of Surgery, University of Iowa, Iowa City.
JAMA Netw Open. 2020 May 1;3(5):e204803. doi: 10.1001/jamanetworkopen.2020.4803.
Perception of weight loss requirements before bariatric surgery varies among patients, physicians, and health insurance payers. Current clinical guidelines do not require preoperative weight loss because of a lack of scientific support regarding its benefits.
To examine the association of preoperative body mass index (BMI) and weight loss with 30-day mortality after bariatric surgery.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study used data from 480 075 patients who underwent bariatric surgery from 2015 to 2017 in the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program, which covers more than 90% of all bariatric surgery programs in the United States and Canada. Clinical and demographic data were collected at all participating institutions using a standardized protocol. Data analysis was performed from December 2018 to November 2019.
Preoperative BMI and weight loss.
30-day mortality after bariatric surgery.
Of the 480 075 patients (mean [SD] age 45.1 [12.0] years; 383 265 [79.8%] women), 511 deaths (0.1%) occurred within 30 days of bariatric surgery. Compared with patients with a preoperative BMI of 35.0 to 39.9, the multivariable-adjusted odds ratios for 30-day mortality for patients with preoperative BMI of 40.0 to 44.9, 45.0 to 49.9, 50.0 to 54.9, and 55.0 and greater were 1.37 (95% CI, 1.02-1.83), 2.19 (95% CI, 1.64-2.92), 2.61 (95% CI, 1.90-3.58), and 5.03 (95% CI, 3.78-6.68), respectively (P for trend < .001). Moreover, compared with no preoperative weight loss, the multivariable-adjusted odds ratios for 30-day mortality for patients with weight loss of more than 0% to less than 5.0%, 5.0% to 9.9%, and 10.0% and greater were 0.76 (95% CI, 0.60-0.96), 0.69 (95% CI, 0.53-0.90), and 0.58 (95% CI, 0.41-0.82), respectively (P for trend = .003).
In this study, even moderate weight loss (ie, >0% to <5%) before bariatric surgery was associated with a lower risk of 30-day mortality. These findings may help inform future updates of clinical guidelines regarding bariatric surgery.
在接受减重手术之前,患者、医生和医疗保险支付方对减肥要求的认知存在差异。由于缺乏减肥益处的科学依据,目前的临床指南并不要求术前减肥。
研究减重手术后 30 天死亡率与术前体重指数(BMI)和减重之间的相关性。
设计、地点和参与者:本队列研究使用了来自 2015 年至 2017 年在美国和加拿大超过 90%的减重手术项目参与的代谢和减重手术认证和质量改进计划(Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program)中 480075 名接受减重手术患者的数据。所有参与机构都使用标准化协议收集临床和人口统计学数据。数据分析于 2018 年 12 月至 2019 年 11 月进行。
术前 BMI 和减重。
减重手术后 30 天的死亡率。
在 480075 名患者(平均[标准差]年龄 45.1[12.0]岁;383265[79.8%]为女性)中,511 人(0.1%)在减重手术后 30 天内死亡。与术前 BMI 为 35.0 至 39.9 的患者相比,术前 BMI 为 40.0 至 44.9、45.0 至 49.9、50.0 至 54.9 和 55.0 及以上的患者 30 天死亡率的多变量调整比值比分别为 1.37(95%置信区间,1.02-1.83)、2.19(95%置信区间,1.64-2.92)、2.61(95%置信区间,1.90-3.58)和 5.03(95%置信区间,3.78-6.68)(趋势 P<0.001)。此外,与无术前减重相比,体重减轻超过 0%至小于 5.0%、5.0%至 9.9%和 10.0%及以上的患者 30 天死亡率的多变量调整比值比分别为 0.76(95%置信区间,0.60-0.96)、0.69(95%置信区间,0.53-0.90)和 0.58(95%置信区间,0.41-0.82)(趋势 P=0.003)。
在这项研究中,即使是轻微的减重(即>0%至<5%)也与降低 30 天死亡率相关。这些发现可能有助于为未来更新减重手术临床指南提供信息。